Ticker: IKT

Inhibikase Therapeutics, Inc. (NASDAQ: IKT) has released its quarterly report for the period ending March 31, 2025, detailing its financial status and operational developments. Here are the key highlights: Income Statement Overview: Total revenues for the quarter were $0, a consistent trend fro...